176 related articles for article (PubMed ID: 33869073)
1. Screening for
Hong JY; Kim A; Park SY; Cho SN; Dockrell HM; Hur YG
Front Cell Infect Microbiol; 2021; 11():599386. PubMed ID: 33869073
[TBL] [Abstract][Full Text] [Related]
2. Host immune responses to antigens derived from a predominant strain of Mycobacterium tuberculosis.
Hur YG; Chung WY; Kim A; Kim YS; Kim HS; Jang SH; Kim Y; Lee H; Park KJ; Cho SN
J Infect; 2016 Jul; 73(1):54-62. PubMed ID: 27155519
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Potential of a PPE Protein Derived from
Kim A; Park KJ; Kim YS; Cho SN; Dockrell HM; Hur YG
Yonsei Med J; 2020 Sep; 61(9):789-796. PubMed ID: 32882763
[TBL] [Abstract][Full Text] [Related]
4. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.
Kim A; Hur YG; Gu S; Cho SN
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927
[TBL] [Abstract][Full Text] [Related]
5. Vaccine efficacy of a
Kwon KW; Choi HH; Han SJ; Kim JS; Kim WS; Kim H; Kim LH; Kang SM; Park J; Shin SJ
FASEB J; 2019 May; 33(5):6483-6496. PubMed ID: 30753099
[No Abstract] [Full Text] [Related]
6. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
7. Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker.
Borgström E; Andersen P; Atterfelt F; Julander I; Källenius G; Maeurer M; Rosenkrands I; Widfeldt M; Bruchfeld J; Gaines H
PLoS One; 2012; 7(11):e43438. PubMed ID: 23144772
[TBL] [Abstract][Full Text] [Related]
8. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.
Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ
J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147
[TBL] [Abstract][Full Text] [Related]
9. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Accuracy of Early Secretory Antigenic Target-6-Free Interferon-gamma Release Assay Compared to QuantiFERON-TB Gold In-tube.
Nemes E; Abrahams D; Scriba TJ; Ratangee F; Keyser A; Makhethe L; Erasmus M; Mabwe S; Bilek N; Rozot V; Geldenhuys H; Hatherill M; Lempicki MD; Holm LL; Bogardus L; Ginsberg AM; Blauenfeldt T; Smith B; Ellis RD; Loxton AG; Walzl G; Andersen P; Ruhwald M
Clin Infect Dis; 2019 Oct; 69(10):1724-1730. PubMed ID: 30668657
[TBL] [Abstract][Full Text] [Related]
11. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
Harada N
Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
[TBL] [Abstract][Full Text] [Related]
13. Potential Immunological Biomarkers for Detection of Mycobacterium tuberculosis Infection in a Setting Where M. tuberculosis Is Endemic, Ethiopia.
Teklu T; Kwon K; Wondale B; HaileMariam M; Zewude A; Medhin G; Legesse M; Pieper R; Ameni G
Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29311240
[TBL] [Abstract][Full Text] [Related]
14. Multiple cytokines for the detection of
Nausch N; Lundtoft C; Schulz G; Henckel H; Mayatepek E; Fleischer B; Marx FM; Jacobsen M
Int J Tuberc Lung Dis; 2017 Mar; 21(3):270-277. PubMed ID: 28225337
[TBL] [Abstract][Full Text] [Related]
15. A Mycobacterium tuberculosis Dormancy Antigen Differentiates Latently Infected Bacillus Calmette-Guérin-vaccinated Individuals.
Peña D; Rovetta AI; Hernández Del Pino RE; Amiano NO; Pasquinelli V; Pellegrini JM; Tateosian NL; Rolandelli A; Gutierrez M; Musella RM; Palmero DJ; Gherardi MM; Iovanna J; Chuluyan HE; García VE
EBioMedicine; 2015 Aug; 2(8):884-90. PubMed ID: 26425695
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the CD4 and CD8 T-cell response in the QuantiFERON-TB Gold Plus kit.
Petruccioli E; Chiacchio T; Pepponi I; Vanini V; Urso R; Cuzzi G; Barcellini L; Palmieri F; Cirillo DM; Ippolito G; Goletti D
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S25-S26. PubMed ID: 28043588
[TBL] [Abstract][Full Text] [Related]
17. Cell-Mediated Immune Responses to
Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
Front Immunol; 2020; 11():103. PubMed ID: 32117257
[TBL] [Abstract][Full Text] [Related]
18. Involvement of methylated HBHA expressed from Mycobacterium smegmatis in an IFN-γ release assay to aid discrimination between latent infection and active tuberculosis in BCG-vaccinated populations.
Wen HL; Li CL; Li G; Lu YH; Li HC; Li T; Zhao HM; Wu K; Lowrie DB; Lv JX; Lu SH; Fan XY
Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1415-1423. PubMed ID: 28429162
[TBL] [Abstract][Full Text] [Related]
19. IFN-γ independent markers of Mycobacterium tuberculosis exposure among male South African gold miners.
Davies LRL; Smith MT; Cizmeci D; Fischinger S; Shih-Lu Lee J; Lu LL; Layton ED; Grant AD; Fielding K; Stein CM; Boom WH; Hawn TR; Fortune SM; Wallis RS; Churchyard GJ; Alter G; Seshadri C
EBioMedicine; 2023 Jul; 93():104678. PubMed ID: 37379655
[TBL] [Abstract][Full Text] [Related]
20. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
Sato S; Nagai H
Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
